SORT BY

FILTER BY

also on other fortune lists

company facts

g500 stats

Global 500

Courtesy of AbbVie

429

AbbVie

ABBV

U.S.

The pharmaceutical company makes drugs to treat HIV, psoriasis, rheumatiod arthritis, low testosterone, thyroid problems, and Parkinson’s.

Looking for leads, investment insights, or competitive intelligence?

CEO

Richard A. Gonzalez

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

North Chicago, IL

Years on Global 500 List

2

Employees

30,000

AbbVie is also featured in these fortune lists
Key Financials (Last Fiscal Year)
($ Millions)% change
Revenues ($M)$25,63812.2%
Profits ($M)$5,953.015.7%
Assets ($M)$66,099
Total Stockholder Equity ($M)$4,636
Profit Ratios
Profit as % of Revenues23.2%
Profits as % of Assets9.0%
Profits as % of Stockholder Equity128.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about AbbVie

Could a New Immunotherapy Medical Approach Break the Alzheimer's Drug Curse?

AbbVie and Alector hope to apply immunotherapy to dementia and Alzheimer's.

Read More →
Valeant's New CEO Joe Papa Has a $17 Billion Ultimatum

If he pulls it off, he will make more than all of his peers combined.

Read More →